MarketCap
Facebook
X
TelegramCRH Medical Corporation Retained Earnings 2011-2026 | CRHM
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings CRH Medical Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -11.9 M | 13.2 M | 12.9 M | 5.41 M | 733 K | -9.83 M | -12.9 M | -14.4 M | -16.9 M | -18.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.2 M | -18.2 M | -5.19 M |
Retained Earnings of other stocks in the Medical instruments industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
382 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
14.9 B | $ 20.1 | 1.85 % | $ 10.3 B | USA |
 |
Luminex Corporation
LMNX
|
83.8 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-120 M | - | -9.52 % | $ 20.6 M | USA |
 |
ICU Medical
ICUI
|
690 M | $ 148.85 | -0.79 % | $ 3.63 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
-223 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
548 M | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.13 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.13 B | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-250 M | $ 8.57 | 2.15 % | $ 173 M | USA |
 |
Alcon
ALC
|
19.4 B | $ 81.03 | -0.12 % | $ 40.4 B |  Schweiz |
 |
Repro Med Systems
KRMD
|
-23.3 M | $ 5.39 | -1.1 % | $ 246 M | USA |
 |
AtriCure
ATRC
|
-402 M | $ 36.9 | -0.14 % | $ 1.73 B | USA |
 |
Haemonetics Corporation
HAE
|
352 M | $ 66.55 | 0.88 % | $ 3.35 B | USA |
 |
electroCore
ECOR
|
-165 M | $ 6.6 | -7.04 % | $ 36.4 K | USA |
 |
AngioDynamics
ANGO
|
-429 M | $ 10.3 | 3.21 % | $ 421 M | USA |
 |
InfuSystem Holdings
INFU
|
-59.3 M | $ 8.27 | 2.73 % | $ 171 M | USA |
 |
OraSure Technologies
OSUR
|
-103 M | $ 2.78 | -0.54 % | $ 207 M | USA |
 |
The Cooper Companies
COO
|
7.64 B | $ 81.34 | 1.21 % | $ 16.2 B | USA |
 |
Masimo Corporation
MASI
|
1.49 B | $ 137.49 | 0.91 % | $ 7.33 B | USA |
 |
Harvard Bioscience
HBIO
|
-146 M | $ 0.5 | -6.73 % | $ 21.2 M | USA |
 |
Glaukos Corporation
GKOS
|
-599 M | $ 119.29 | 0.28 % | $ 5.78 B | USA |
 |
Merit Medical Systems
MMSI
|
696 M | $ 80.93 | 0.85 % | $ 4.71 B | USA |
 |
Isoray
ISR
|
-232 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
-759 M | $ 154.21 | 3.5 % | $ 4.81 B | USA |
 |
LeMaitre Vascular
LMAT
|
145 M | $ 84.97 | 1.32 % | $ 1.91 B | USA |
 |
STERIS plc
STE
|
2.48 B | $ 261.9 | 0.02 % | $ 25.8 B | USA |
 |
Intuitive Surgical
ISRG
|
6.8 B | $ 505.17 | -0.47 % | $ 179 B | USA |
 |
NeuroMetrix
NURO
|
-218 M | - | 5.05 % | $ 9.02 M | USA |
 |
Microbot Medical
MBOT
|
-79.5 M | $ 1.81 | -2.96 % | $ 18.5 M |  Israel |
 |
Utah Medical Products
UTMD
|
138 M | $ 61.21 | -0.71 % | $ 222 M | USA |
 |
Nephros
NEPH
|
-144 M | $ 4.35 | -0.91 % | $ 45.2 M | USA |
 |
Milestone Scientific
MLSS
|
-128 M | $ 0.29 | -2.67 % | $ 23.1 M | USA |
 |
Envista Holdings Corporation
NVST
|
-487 M | $ 23.4 | 0.13 % | $ 4.03 B | USA |
 |
Pro-Dex
PDEX
|
35.9 M | $ 38.77 | -1.61 % | $ 127 M | USA |
 |
Predictive Oncology
POAI
|
-180 M | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
-337 M | $ 13.76 | 0.99 % | $ 661 M | USA |
 |
Becton, Dickinson and Company
BDX
|
16.6 B | $ 203.2 | 1.05 % | $ 58.5 B | USA |
 |
Repligen Corporation
RGEN
|
433 M | $ 150.44 | -3.8 % | $ 8.38 M | USA |
 |
ResMed
RMD
|
3.61 B | $ 256.15 | -0.57 % | $ 37.4 B | USA |
 |
BioLife Solutions
BLFS
|
-335 M | $ 21.91 | -2.97 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
-538 M | $ 2.21 | -5.36 % | $ 178 M | USA |
 |
Retractable Technologies
RVP
|
26.7 M | $ 0.7 | -1.03 % | $ 21 M | USA |
 |
STAAR Surgical Company
STAA
|
-67.6 M | $ 18.9 | -0.24 % | $ 928 M | USA |
 |
Teleflex Incorporated
TFX
|
4.12 B | $ 104.44 | -0.96 % | $ 4.89 B | USA |
 |
West Pharmaceutical Services
WST
|
3.96 B | $ 231.57 | -0.4 % | $ 16.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-835 M | $ 12.47 | 1.63 % | $ 2.53 B | USA |